
Chemists Investigate Casanova’s Clap
In his memoirs, the womanizing writer Giacomo Casanova described suffering several bouts of gonorrhea—but researchers found no trace of the microbe on his handwritten journals. Karen Hopkin reports.

Chemists Investigate Casanova’s Clap
In his memoirs, the womanizing writer Giacomo Casanova described suffering several bouts of gonorrhea—but researchers found no trace of the microbe on his handwritten journals. Karen Hopkin reports.

Experimental Autism Drugs Aim to Improve Social Communication Skills
Experts caution that addressing lingering questions will require more research.


How to Kill HIV: Target Its “Influencers”
Applying network theory to HIV’s structure has revealed the most valuable—and vulnerable—parts of the virus

U.S. Measles Cases Top 700 This Year as Health Officials Urge Vaccinations
The surge in cases has sent 66 children to the hospital, according to the Centers for Disease Control and Prevention

First Proven Malaria Vaccine Rolled Out in Africa—But Doubts Linger
The vaccine is up to 40 percent effective at preventing malaria in young children

We Need New Ideas for Fighting Alzheimer’s
Treatments based on the “amyloid hypothesis” have failed; it’s time to focus on inflammation instead

Pain Patients Get Relief from War on Opioids
U.S. agencies warn doctors not to abruptly cut off the medications for long-time users

Gluten-Free Restaurant Foods Are Often Mislabeled
One in three gluten-free dishes tested at restaurants contained gluten—especially GF pizzas and pastas. Christopher Intagliata reports.

Where AI in Medicine Falls Short
It can help with diagnosis but not yet with helping physicians and patients decide what to do with the information

How the World’s First Dengue Vaccination Drive Ended in Disaster
Is a runaway immune reaction making a dengue vaccine dangerous?

A New Way to Fight Cancer
Metabolic therapy is showing promise in robbing malignant cells of their primary energy source

A Repurposed Drug Could Offer Hope after Many Alzheimer's Trial Failures
An experimental drug for hepatitis D triggers a cellular waste disposal system to rid mice brains of the tau protein, a major culprit in neurodegenerative disease